Icecure Medical (ICCM) Stock Price, News, Quotes-Moomoo

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

IceCure Medical Ltd (ICCM) Q3 2024 Earnings Call Transcript Summary
moomoo AI14:01 ET · Conference Call
IceCure Medical Price Target Raised to $4.60 From $4.16 at Brookline
TipRanks13:50 ET
IceCure Medical GAAP EPS of $0.22 , Revenue of $2.41M
Seeking AlphaNov 26 09:05 ET
Icecure Medical | 6-K: Report of foreign private issuer (related to financial reporting)
SECNov 26 08:37 ET · Announcements
Press Release: IceCure Medical Reports 36% Sales Growth in the First Nine Months of 2024 Driven by Global Adoption of ProSense(R) Cryoablation
Dow JonesNov 26 08:30 ET
Earnings Scheduled For November 26, 2024
BenzingaNov 26 03:32 ET

Comments

Trytosaveabit

7 hours ago

Pay attention to upcoming possible catalysts! Make a note to keep on your mind! That is if you’re looking for a possible ST! NFA

$Icecure Medical (ICCM.US)$ Financial Performance:
ProSense systems and disposable probe sales increased by 36% to $2.32 million for the nine months ending September 30, 2024, compared to the previous year.
Total revenue grew by 22% to $2.42 million in the same period, driven by higher sales in Europe, the US, and Japan.
Gross profit increased by 41% to $1.03 million, an...

1

Jaguar8

13 hours ago

NEWS

$Icecure Medical (ICCM.US)$
IceCure Medical Reports 36% Sales Growth in the First Nine Months of 2024 Driven by Global Adoption of ProSense® Cryoablation
IceCure Medical reported strong financial results for the first nine months of 2024, with 36% growth in ProSense® system and probe sales to $2.3M.
Gross profits increased 41%, with non-GAAP gross profits up 104%.
Gross margins improved to 43% from 37% year-over-year.
The FDA Advisory Panel voted favorably for ProSense®'s benefit-risk prof...

2

1

Jaguar8

22 hours ago

MY WATCHLIST TUESDAY (November 26). Trade the Chart. Don’t open position impulsively.

I WILL UPDATE IF I FIND MORE
$Poseida Therapeutics (PSTX.US)$ ✔️TOP PLAY. To be acquired by Roche for $1.5B for $9.00/share. “Poseida stockholders to receive up to $13.00 per share in cash, comprised of $9.00 per share in cash at closing and a non-tradeable contingent value right (CVR) to receive up to an aggregate of $4.00 per share in cash”
$Citius Pharmaceuticals (CTXR.US)$✔️ News halt after hours + PR today o...

Bitcoin ups and downs: How far is it from $100,000?

37

7

Jaguar8

Nov 25 07:36

NEWS

$Icecure Medical (ICCM.US)$
IceCure's Next-Generation Multiprobe Cryoablation Technology Issued Notice of Allowance from Japan's Patent Office
IceCure Medical (NASDAQ: ICCM) has received a Notice of Allowance from Japan's Patent Office for its 'Cryogenic System with Multiple Submerged Pumps' invention. This technology enables a next-generation MSense™ multiprobe cryoablation system that can independently control multiple cryoprobes for treating larger tumors. The patent strengthens IceCure's ...

1

Trytosaveabit

Nov 25 07:32

News

$Icecure Medical (ICCM.US)$ Reuters· 1 min ago
Icecure's Next-Generation Multiprobe Cryoablation Technology Issued Notice of Allowance From Japan's Patent Office

ICCM Icecure Medical

Trade Overview

Capital Trend

News

Comments

Analysis

Analyst Rating

Price Target